Similar Papers

Paper Title
Journal
Date
Author
440 Utilizing Stim-RTM technology to reduce live feeder cells in the tumor infiltrating lymphocyte culture process
Riley P Allen ... Alexander Cheung
Journal for ImmunoTherapy of Cancer | VOL. 12
Riley P Allen, et. al.Riley P Allen ... Alexander Cheung
01 Nov 2024
Abstract B023: Using hypoxia to improve tumor infiltrating lymphocytes therapy in different subtypes of renal cell carcinoma
Marine Potez ... Mohammed Alkhouli
Cancer Research | VOL. 83
Marine Potez, et. al.Marine Potez ... Mohammed Alkhouli
15 Aug 2023
Abstract LB-110: Anti-OX40 agonistic antibody enhances ex vivo CD8+ TIL expansion with increased T-cell effector function
Krit Ritthipichai ... Cecile Chartier
Cancer Research | VOL. 78
Krit Ritthipichai, et. al.Krit Ritthipichai ... Cecile Chartier
01 Jul 2018
465 Generation of tumor-reactive T cell-enriched tumor infiltrating lymphocytes(TILs) product with autologous patient-derived organoid(PDO)
Zhenjiang Liu ... Yarong Liu
Journal for ImmunoTherapy of Cancer | VOL. 12
Zhenjiang Liu, et. al.Zhenjiang Liu ... Yarong Liu
01 Nov 2024
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
Alessio Cortellini ... Biagio Ricciuti
Journal for ImmunoTherapy of Cancer | VOL. 13
Alessio Cortellini, et. al.Alessio Cortellini ... Biagio Ricciuti
04 Feb 2025
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis
Cameron Wood ... Neal Ready
Journal for ImmunoTherapy of Cancer | VOL. 13
Cameron Wood, et. al.Cameron Wood ... Neal Ready
04 Feb 2025
Modulating lipid metabolism improves tumor immunotherapy
Yu Ping ... Yi Zhang
Journal for ImmunoTherapy of Cancer | VOL. 13
Yu Ping, et. al.Yu Ping ... Yi Zhang
04 Feb 2025
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma
Thomas Eigentler ... Ulrike Gnad-Vogt
Journal for ImmunoTherapy of Cancer | VOL. 13
Thomas Eigentler, et. al.Thomas Eigentler ... Ulrike Gnad-Vogt
04 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.